Skip to main content

Advertisement

Figure 5 | Arthritis Research & Therapy

Figure 5

From: Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

Figure 5

Effect of infliximab (Ifx) and etanercept (Eta) treatment on anti-mycobacterial responses. The effect of 14-week treatment with Ifx or with Eta on interferon (IFN)-γ release induced by purified protein derivative (PPD) in patients from group I, (a) or in patients from group II (b). The effect of 14-week treatment with Ifx or with Eta on interferon (IFN)-γ release induced by culture filtrate protein (CFP)-10 was determined in patients from group II (c). Results are expressed (mean ± standard error of the mean) as number of interferon (IFN)-γ-producing cells per 106 cells. n = 13 and 16 for Ifx and Eta respectively in (a). n = 11 for both Ifx and Eta in (b) and (c). *p < 0.01 for comparisons between week 0 and week 14 (Wilcoxon test).

Back to article page